ANRO

COM:ALTONEUROSCIENCE

Alto Neuroscience

  • Stock

USD

Last Close

4.09

22/11 21:00

Market Cap

338.20M

Beta: -

Volume Today

362.06K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
asset turnover
0.01
-
cash conversion cycle
1.52K
-
cash per share
1.01
-
1.89
88.07%
company equity multiplier
-2.31
-
-1.32
42.62%
days of inventory outstanding
-0.00
-
days of payables outstanding
1.51K
-
1.71K
13.48%
days of sales outstanding
3.03K
-
dividend yield
ebit per revenue
-57.41
-
ebt per ebit
0.76
-
0.95
24.57%
effective tax rate
enterprise value multiple
-45.49
-
-19.52
57.09%
fixed asset turnover
0.20
-
free cash flow per share
-0.39
-
-0.83
112.49%
gross profit margin
0.31
-
interest coverage
inventory turnover
-39.84T
-
long term debt to capitalization
1.49
-
1.89
27.01%
net income per ebt
1
-
1
0%
net profit margin
-43.75
-
operating cash flow per share
-0.36
-
-0.80
120.19%
operating cycle
3.03K
-
operating profit margin
-57.41
-
payables turnover
0.24
-
0.21
11.88%
pretax profit margin
-43.75
-
price fair value
-42.43
-
-13.78
67.51%
receivables turnover
0.12
-
return on assets
-0.32
-
-0.54
70.78%
return on capital employed
-0.45
-
-0.64
44.25%
return on equity
0.74
-
0.72
2.00%
total debt to capitalization
1.49
-
1.88
26.62%

All numbers in USD (except ratios and percentages)